The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kelly Thomas Patrick since year 2005.
The trader's CIK number is 1410514.
At the time of this reporting, Kelly Thomas Patrick is the Chief Financial Officer of Deciphera Pharmaceuticals, Inc. .
(stock ticker symbol DCPH).
See this page for all insider trading activities at Deciphera Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-02-19||DCPH||Deciphera Pharmaceuticals, Inc.||Sale||1,500||30.00||45,000|
|2019-02-19||DCPH||Deciphera Pharmaceuticals, Inc.||Option Ex||1,500||1.89||2,835|
|2019-01-07||DCPH||Deciphera Pharmaceuticals, Inc.||Option Ex||5,000||1.89||9,450|
|2019-01-07||DCPH||Deciphera Pharmaceuticals, Inc.||Sale||5,000||25.18||125,900|
|2007-08-22||CRTX||Critical Therapeutics Inc||Buy||4,000||2.08||8,316|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kelly Thomas Patrick (Chief Financial Officer of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.